APA (7th ed.) Citation

A, S., L, L., TS, J., M, E., & AL, S. (2015). Upregulated interleukin-6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma. Molecular oncology, 9(7), 1371. https://doi.org/10.1016/j.molonc.2015.03.008

Chicago Style (17th ed.) Citation

A, Stanam, Love-Homan L, Joseph TS, Espinosa-Cotton M, and Simons AL. "Upregulated Interleukin-6 Expression Contributes to Erlotinib Resistance in Head and Neck Squamous Cell Carcinoma." Molecular Oncology 9, no. 7 (2015): 1371. https://doi.org/10.1016/j.molonc.2015.03.008.

MLA (9th ed.) Citation

A, Stanam, et al. "Upregulated Interleukin-6 Expression Contributes to Erlotinib Resistance in Head and Neck Squamous Cell Carcinoma." Molecular Oncology, vol. 9, no. 7, 2015, p. 1371, https://doi.org/10.1016/j.molonc.2015.03.008.